SUSQUEHANNA INTERNATIONAL GROUP, LLP - ADIAL PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

ADIAL PHARMACEUTICALS INC's ticker is ADILW and the CUSIP is 00688A114. A total of 2 filers reported holding ADIAL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$16,000
+433.3%
43,372
+162.8%
0.00%–
Q3 2019$3,000
-66.7%
16,505
-65.6%
0.00%–
Q2 2019$9,000
+125.0%
48,045
+336.8%
0.00%–
Q1 2019$4,000
-60.0%
11,000
-39.1%
0.00%–
Q4 2018$10,000–18,069–0.00%–
 Download
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
UBS Group AG 2$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
WOLVERINE ASSET MANAGEMENT LLC 4,300$3,0000.00%
AMERIPRISE FINANCIAL INC 15,000$14,0000.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders